Aris Water Solutions (NYSE:ARIS) Hits New 52-Week High at $17.95

Medpace (NASDAQ:MEDP) Given New $362.00 Price Target at Robert W. Baird



Robert W. Baird lifted their target price on Medpace from $354.00 to $362.00 and gave the company a “neutral” rating in a research report on Monday.



Source link

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *